Clinical Trial Update: Comparison of the Postoperative Use of Dextenza vs a Standard Regimen After PRK [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing postoperative use of Dextenza versus standard regimen after PRK (a steroid ophthalmic insert study).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Refractive Surgery Complications
• Myopia Correction-related Conditions
• Steriod Ophthalmic Insert-related Indications

Drugs mentioned

• Dextenza (Dexamethasone)

Snippet

Sponsor: Navy Medical Center San Diego | Conditions: Steroid Ophthalmic Insert | Phase 4 | Status: UNKNOWN